Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER 84INDUSTRY 70NIH 16NETWORK 4OTHER_GOV 1

Study Type

Observational 1

Sponsor

Cancer Type

Genitourinary 7Thoracic 1Gastrointestinal 1Dermatologic 1

Conditions

Colorectal Neoplasms 133Stomach Neoplasms 107Carcinoma, Hepatocellular 73Rectal Neoplasms 64Esophageal Neoplasms 53Pancreatic Neoplasms 52Colonic Neoplasms 52Neoplasms 28Neoplasm Metastasis 20Esophageal Squamous Cell Carcinoma 20Gastrointestinal Neoplasms 19Cholangiocarcinoma 14Liver Neoplasms 13Breast Neoplasms 13Barrett Esophagus 9Lung Neoplasms 8Adenoma 8Motor Activity 7Liver Cirrhosis 7Digestive System Neoplasms 7Colonic Polyps 7Adenomatous Polyposis Coli 7Biliary Tract Neoplasms 6Anastomotic Leak 6Sarcopenia 5Inflammatory Bowel Diseases 5Hypertension, Portal 5Gallbladder Neoplasms 5Carcinoma, Non-Small-Cell Lung 5Uterine Cervical Neoplasms 4

Interventions

Blood Cell Count 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER_GOV × Kidney Neoplasms × Gastrointestinal × Clear all
NCT07485114 2026-03-20

Association Between Galectin-3 Levels and Outcomes in Patients With Renal Cell Carcinoma, Transitional Cell Carcinoma , Non Small Cell Lung Cancer, and Hepatocellular Carcinoma, Treated With PD-1/PDL-1 Inhibitors

Tel-Aviv Sourasky Medical Center

Recruiting
300 enrolled
GastrointestinalGenitourinaryThoracic

Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Carcinoma, Transitional Cell, Carcinoma, Hepatocellular, Kidney Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡